Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

v3.22.2.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balances (in shares) at Jun. 30, 2019     37,934,000          
Balances at Jun. 30, 2019 $ (879) $ (879) $ 379 $ 316,797 $ 931,934 $ (83,521)   $ 1,165,589
Net earnings         229,296     229,296
Other comprehensive income (loss)           (13,678)   $ (13,678)
Share repurchases (in shares)     (279,000)         (279,381)
Share repurchases     $ (3)   (50,109)     $ (50,112)
Surrender and retirement of stock to exercise option (in shares)     (2,000)          
Surrender and retirement of stock to exercise option       (400)       $ (400)
Common stock issued for exercise of options (in shares)     730,000         743,000
Common stock issued for exercise of options     $ 7 69,461 (1,642)     $ 67,826
Common stock issued for restricted stock awards (in shares)     56,000          
Common stock issued for restricted stock awards     $ 1 (1) (2,229)     (2,228)
Cash dividends         (48,902)     (48,902)
Stock-based compensation expense       31,932       31,932
Common stock issued to employee stock purchase plan (in shares)     14,000          
Common stock issued to employee stock purchase plan       2,312       2,312
Employee stock purchase plan expense       435       435
Balances (in shares) at Jun. 30, 2020     38,453,000          
Balances at Jun. 30, 2020 $ (276) $ (276) $ 385 420,536 1,057,470 (97,199)   1,381,192
Non-controlling interest in Eminence             $ 8,985 8,985
Net earnings         140,410   (825) 139,585
Other comprehensive income (loss)           39,908 103 $ 40,011
Share repurchases (in shares)     (120,000)         (120,000)
Share repurchases     $ (1)   (43,177)     $ (43,178)
Common stock issued for exercise of options (in shares)     573,000         627,000
Common stock issued for exercise of options     $ 6 62,102 (12,287)     $ 49,821
Common stock issued for restricted stock awards (in shares)     38,000          
Common stock issued for restricted stock awards     $ 0 0 (7,057)     (7,057)
Cash dividends         (49,622)     (49,622)
Stock-based compensation expense       48,065       48,065
Common stock issued to employee stock purchase plan (in shares)     11,000          
Common stock issued to employee stock purchase plan     $ 0 2,791       2,791
Employee stock purchase plan expense       917       $ 917
Balances (in shares) at Jun. 30, 2021     38,955,000         38,955,484
Balances at Jun. 30, 2021     $ 390 534,411 1,085,461 (57,291) 8,263 $ 1,571,234
Net earnings         272,051   (8,952) 263,099
Other comprehensive income (loss)           (17,909) (70) $ (17,979)
Share repurchases (in shares)     (394,000)         (394,238)
Share repurchases     $ (4)   (160,946)     $ (160,950)
Common stock issued for exercise of options (in shares)     570,000         613,000
Common stock issued for exercise of options     $ 6 74,371 (13,482)     $ 60,895
Common stock issued for restricted stock awards (in shares)     22,000          
Common stock issued for restricted stock awards     $ 0 0 (9,978)     (9,978)
Cash dividends         (50,185)     (50,185)
Stock-based compensation expense       41,208       41,208
Common stock issued to employee stock purchase plan (in shares)     7,000          
Common stock issued to employee stock purchase plan     $ 0 2,694       2,694
Employee stock purchase plan expense       973       $ 973
Balances (in shares) at Jun. 30, 2022     39,160,000         39,160,000
Balances at Jun. 30, 2022     $ 392 $ 653,657 $ 1,122,921 $ (75,200) $ (759) $ 1,701,011